Litcius/Paper detail

1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)

Beate Rau, Hauke Lang, Alfred Königsrainer, Ines Gockel, H. Rau, Hendrik Seeliger, Christian Lerchenmüller, Daniel Reim, Roger Wahba, Martin K. Angele, Steffen Heeg, Tobias Keck, Arved Weimann, Sascha Topp, P. Piso, Andreas Brandl, Evelyn Trips, Volker Heinemann, P. Thuss-Patience

2021Annals of Oncology37 citationsDOI

Topics & Concepts

MedicineCytoreductive surgeryHyperthermic intraperitoneal chemotherapyChemotherapyRandomized controlled trialMetastasisCancerSurgeryOncologyInternal medicineOvarian cancerIntraperitoneal and Appendiceal MalignanciesNeuroendocrine Tumor Research AdvancesGastrointestinal Tumor Research and Treatment
1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial) | Litcius